Archives

Leading global investor backs U.S. Urology Partners’ next stage of growth as a comprehensive platform of patient-centric practice management solutions for independent, community-based urology [...]

 Zachary Klaassen speaks with Steven Finkelstein about the FDA approval of Pluvicto™ (177Lu-PSMA-617) in the pre-chemotherapy setting for metastatic castration-resistant prostate cancer. Dr. [...]